Zusammenfassung
Dieses Kapitel befasst sich mit den wesentlichen Charakteristika des Erbium:YAG-Lasers. Hierzu zählen die Indikationen, die physikalischen und medizinischen Eigenschaften, die Planung der Durchführung, Kontraindikationen und mögliche Nebenwirkungen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Kardorff B, (2015). Selbstzahlerleistungen in der Dermatologie und der ästhetischen Medizin. 2. Auflage. Springer, Berlin, Heidelberg
Raulin C, Karsai S, (2013). Lasertherapie der Haut. Springer, Berlin, Heidelberg
Landthaler M, Hohenleutner U, (2006). Lasertherapie in der Dermatologie. Atlas und Lehrbuch. 2., vollständig überarbeitete Auflage. Springer, Berlin, Heidelberg
Alexiades-Armenakas MR, Dover JS, Arndt KA, (2008). The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol. 58(5):719-37
Freedman JR, Greene RM, Green JB (2014) Histologic effects of resurfacing lasers. Facial Plast Surg 30:40-48
Schmitt L, Amann PM, Marquardt Y, Heise R, Czaja K, Gerber PA, Steiner T, Hölzle F, Baron JM, (2017). Molecular effects of fractional ablative erbium:YAG laser treatment with multiple stacked pulses on standardized human three-dimensional organotypic skin models. Lasers Med Sci. 2017 May;32(4):805-814
Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR, (2004). Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34(5):426-38
Braun SA, Schrumpf H, Buhren BA, Homey B, Gerber PA, (2016). Laser-assisted drug delivery: mode of action and use in daily clinical practice. J Dtsch Dermatol Ges. 14(5):480-8. doi: 10.1111/ddg.12963. Review
Togsverd-Bo K, Haak CS, Thaysen-Petersen D, Wulf HC, Anderson RR, Hædersdal M, (2012). Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial. Br J Dermatol. 2012 Jun;166(6):1262-9
Alp E, Bijl D, Bleichrodt RP, Hansson B, Voss AJ (2006). Surgical smoke and infection control. Hosp Infect. 62(1):1-5
Barrett WL (2003). Surgical smoke: a review of the literature. Surg Endosc 17:979-987
Bree K, Barnhill S, Rundell W, (2017). The Dangers of Electrosurgical Smoke to Operating Room Personnel: A Review. Workplace Health Saf. 2017 Apr 1:2165079917691063
Baggish MS, Poiesz BJ, Joret D, Williamson P, Refal A (1991). Presence of human immunodeficiency DNA in laser smoke. Lasers Surg Med 11: 197-203
Garden JM, O’Banion MK, Bakus AD, Olson C (2002). Viral disease transmitted by laser-generated plume (aerosol). Arch Dermatol; 138:1303-1307
Hallmo P, Naess O, (1991). Laryngeal papillomatosis with human papillomavirus DNA contracted by a laser surgeon. Eur Arch Otohinolaryngol;248:425-427
Gloster H, Roenigk R, (1995). Risk of acquiring human papillomavirus from the plume produced by the carbon dioxide laser in the treatment of warts. J Am Acad Dermatol;32:436-441
Canadian Standards Association, (2013). Plume scavenging in surgical, diagnostic, therapeutic and aesthetic settings (Z305.13-13). Mississauga, Ontario: Canadian Standards Association
Makiyama K, Hirai R, Matsuzaki H, (2017).Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men: First Report: Changes in HPV Antibody Titer. J Voice. 31(1):104-106
Robati RM, Asadi E, (2017). Efficacy and safety of fractional CO2 laser versus fractional Er:YAG laser in the treatment of facial skin wrinkles. Lasers Med Sci. 2017 Feb;32(2):283-289
Forster B, Klein A, Szeimies RM, Maisch T (2010) Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation. Exp Dermatol 19:806-812
Huth S, Marquardt Y, Amann PM, Leverkus M, Huth L, Baron JM, Gerber PA, (2016). Ablative non-sequential fractional ultrapulsed CO2 laser pretreatment improves conventional photodynamic therapy with methyl aminolevulinate in a novel human in vitro 3D actinic keratosis skin model. Exp Dermatol. 25(12):997-999
Togsverd-Bo K, Lei U, Erlendsson AM, Taudorf EH, Philipsen PA, Wulf HC, Skov L, Hædersdal M, (2015). Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients – a randomized controlled trial Br J Dermatol. 172(2):467-74
Braun SA, Gerber PA, (2017). Lesion intensified field therapy (LIFT): A new concept in the treatment of actinic field cancerization. J Eur Acad Dermatol Venereol. 31(5):e232-e233
Philipp-Dormston WG, Karrer S, Petering H, Ulrich C, Dirschka T, Berking C, Lonsdorf AS, Gerber PA, Radakovic S, Hunger RE, Szeimies RM, (2015). Daylight PDT with MAL - current data and practical recommendations of an expert panel. J Dtsch Dermatol Ges. 13(12):1240-9
Kim SK, Park JY, Song HS et al. Photodynamic therapy with ablative carbon dioxide fractional laser for treating Bowen disease. Ann Dermatol 2013; 25: 335-9
Lippert J, Smucler R, Vlk M. Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate. Dermatol Surg 2013; 39: 1202-8
Yoo KH, Kim BJ, Kim MN. Enhanced efficacy of photodynamic therapy with methyl 5-aminolevulinic acid in recalcitrant periungual warts after ablative carbon dioxide fractional laser: a pilot study. Dermatol Surg 2009; 35: 1927-32
Braun SA, Homey B, Hevezi P, Gerber PA. Laser assisted drug delivery: Enhanced response to Ingenol mebutate after ablative fractional laser treatment. J Am Acad Dermatol 2015; 72(2): 364-5
Waibel JS, Wulkan AJ, Shumaker PR. Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery. Lasers Surg Med 2013; 45: 135-40
Lee WR, Shen SC, Kuo-Hsien W et al. Lasers and microdermabrasion enhance and control topical delivery of vitamin C. J Invest Dermatol 2003; 121: 1118-25
Trelles MA, Leclere FM, Martinez-Carpio PA. Fractional carbon dioxide laser and acoustic-pressure ultrasound for transepidermal delivery of cosmeceuticals: a novel method of facial rejuvenation. Aesthetic Plast Surg 2013; 37: 965-72
Lee WR, Shen SC, Fang CL et al. Topical delivery of methotrexate via skin pretreated with physical enhancement techniques: low-fluence erbium:YAG laser and electroporation. Lasers Surg Med 2008; 40: 468-76
Lee WR, Pan TL, Wang PW et al. Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination. J Control Release 2008; 128: 200-8
Oni G, Lequeux C, Cho MJ et al. Transermal delivery of adipocyte-derived stem cells using a fractional ablative laser. Aesthet Surg J 2013; 33: 109-16.
Delker S, Livingstone E, Schimming T, Schadendorf D, Griewank KG. Melanoma diagnosed in lesions previously treated by laser therapy. J Dermatol. 2016 Jun 27. doi: 10.1111/1346-8138.13484
Braun SA, Artzi O, Gerber PA, (2017). Brimonidine tartrate 0.33% gel for the management of posttreatment erythema induced by laser skin resurfacing. J Am Acad Dermatol. 2017 Feb;76(2):e53-e55
Ho C, Nguyen Q, Lowe NJ, et al. Laser resurfacing in pigmented skin. Dermatol Surg 1995;21:1035-7
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Gerber, P.A. (2018). Erbium:YAG-Laser (Er:YAG-Laser). In: Kautz, G. (eds) Energie für die Haut. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-56436-3_14
Download citation
DOI: https://doi.org/10.1007/978-3-662-56436-3_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-56435-6
Online ISBN: 978-3-662-56436-3
eBook Packages: Medicine (German Language)